CARDIOPROTECTIVE ACTIVITY OF EMPAGLIFLOZIN AND LIRAGLUTIDE WITH OR WITHOUT METFORMIN IN DIABETIC RATS INDUCED BY ACUTE MYOCARDIAL INFARCTION
DM patients with comorbid cardiovascular disease are recommended to use sodium glucose cotransporter-2 inhibitors (SGLT2i) and glucagon like Peptide 1 receptor agonist (GLP1-RA) which have been proven to reduce the risk of complications of myocardial infarction. In addition, metformin is also th...
محفوظ في:
| المؤلف الرئيسي: | |
|---|---|
| التنسيق: | Theses |
| اللغة: | Indonesia |
| الوصول للمادة أونلاين: | https://digilib.itb.ac.id/gdl/view/78113 |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|